“He Yuan Li Ji” was established as a joint venture between He Yuan Bio (stock code: 688238) and Li Ji Bio, with its core business centered on the “Li Ji Bio” and “Life-ilab” reagent brands.

Select language:

中文

English

Low-toxicity cell transfection reagent enables efficient gene delivery.

Publication date:2024-03-26
Page views:

Cell transfection is a widely used technique in modern life sciences, employed to deliver exogenous genes or RNA molecules into cells for investigating gene function, disease mechanisms, and other biological processes. However, conventional cell transfection reagents often exhibit cytotoxicity and cause cellular damage, thereby limiting their broad application in research and clinical settings.

Low-toxicity cell transfection reagent It employs a novel chemical formulation that exhibits low cytotoxicity and minimal cellular damage, thereby preserving cell integrity and physiological function. It enables efficient gene delivery, achieving high transfection efficiency. Moreover, it can effectively introduce exogenous genes or RNA molecules into cells, facilitating precise studies of gene function and regulation. With excellent chemical stability, it maintains consistent transfection performance across diverse cell lines and experimental conditions, enhancing the reproducibility and comparability of experiments.

Low‑toxicity cell transfection reagents are widely used in the field of gene function research. By delivering exogenous genes into cells, researchers can perform gene knockout, overexpression, and targeted genome editing, thereby elucidating gene functions and regulatory mechanisms. These reagents also play a crucial role in drug screening and development: they can be employed to introduce drug‑target genes, assess drug efficacy and toxicity, and provide robust preclinical data to support drug discovery. Furthermore, they are extensively applied in gene therapy and genetic engineering; by delivering therapeutic genes into patients or performing genetic modifications, they enable the potential for curative gene therapies and drive innovation in biotechnology.

Low‑toxicity cell transfection reagents offer high efficiency and stability, enhancing both the productivity and reliability of research. They enable rapid and precise gene delivery, freeing scientists to devote more time and energy to in‑depth investigations. By minimizing cellular damage and cytotoxic effects, these reagents help preserve cell integrity and physiological functions—key considerations for cell biology studies and cell‑based therapies. The advent of low‑toxicity cell transfection reagents has expanded the possibilities and opportunities in scientific research, providing safe and dependable technical support for innovations in areas such as gene function analysis and disease treatment, thereby advancing the field of life sciences.

%{tishi_zhanwei}%